Cholecystokinin and panic disorder
- 1 April 2004
- journal article
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 16 (2) , 85-93
Abstract
Evidence for implication of cholecystokinin (CCK) in the neurobiology of panic disorder is reviewed through animal and human pharmacological studies. The results of these investigations raise two issues: (i) selectivity of action of CCK-2 agonists in anxiety disorders; and (ii) aberrations of the CCK system in anxiety disorders, both of which are discussed.Keywords
This publication has 72 references indexed in Scilit:
- Increased ACTH Concentrations Associated with Cholecystokinin Tetrapeptide-Induced Panic Attacks in Patients with Panic DisorderNeuropsychopharmacology, 2000
- Two faces of cholecystokinin: anxiety and schizophreniaFundamental & Clinical Pharmacology, 1996
- Molecular Cloning and Functional Expression of the Human Gallbladder Cholecystokinin A ReceptorBiochemical and Biophysical Research Communications, 1993
- CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sitesNeuroReport, 1992
- Cholecystokinin, gastrin and stress hormone responses in marathon runnersPeptides, 1992
- The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical studyBrain Research, 1989
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984
- Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitroLife Sciences, 1980
- Cholecystokinin octapeptide releases growth hormone from the pituitaryLife Sciences, 1979
- Cholecystokinin, motilin and secretin effects on the central nervous systemPhysiology & Behavior, 1979